Is hydrocodone (hydrocodone)-acetaminophen 10-325, 2 tablets every 8 hours equivalent to long-acting oxycodone (oxycondone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Opioid Dose Equivalence Calculation

Hydrocodone-acetaminophen 10-325 mg, 2 tablets every 8 hours (60 mg hydrocodone daily) is equivalent to approximately 40 mg of long-acting oxycodone per day, which would typically be dosed as OxyContin 20 mg twice daily. 1, 2

Morphine Milligram Equivalent (MME) Calculation

The CDC Clinical Practice Guideline provides standardized conversion factors for calculating opioid equivalence: 1

  • Hydrocodone conversion factor: 1.0 1
  • Oxycodone conversion factor: 1.5 1

Your Current Regimen

  • Hydrocodone 10 mg × 2 tablets = 20 mg per dose 2
  • Dosed every 8 hours = 3 doses per day
  • Total daily hydrocodone: 60 mg 2
  • Total daily MME: 60 mg × 1.0 = 60 MME/day 1

Equivalent Long-Acting Oxycodone Dose

  • Using the conversion factors: 60 mg hydrocodone ÷ 1.0 × 1.5 = 90 MME from oxycodone perspective 1
  • Converting to oxycodone dose: 90 MME ÷ 1.5 = 60 mg oxycodone equivalent 2
  • However, oxycodone is approximately 1.5 times more potent than hydrocodone on a milligram basis 2
  • Therefore: 60 mg hydrocodone ≈ 40 mg oxycodone daily 2

Critical Conversion Cautions

The CDC explicitly warns against using calculated MME doses directly for opioid conversions. 1 When converting between opioids:

  • The new opioid should be dosed substantially lower than the calculated MME dose to avoid overdose due to incomplete cross-tolerance and individual pharmacokinetic variability 1
  • A typical reduction of 25-50% from the calculated equivalent dose is standard practice when rotating opioids 1
  • Equianalgesic conversions are only estimates and cannot account for individual genetic and pharmacokinetic variability 1

Long-Acting Oxycodone Formulation Considerations

Extended-release oxycodone (OxyContin) is dosed twice daily and should only be used in opioid-tolerant patients. 2 Key considerations:

  • OxyContin is indicated for chronic pain management, not acute pain 2
  • It is not intended for "as-needed" use 2
  • The patient on 60 mg daily hydrocodone would be considered opioid-tolerant 2
  • Typical conversion: OxyContin 20 mg twice daily (40 mg total daily) would be the starting point, with further titration based on response 2

Dosage Threshold Warning

This regimen places the patient at 60 MME/day, which approaches the CDC's 50 MME/day threshold requiring careful reassessment. 1 Important considerations:

  • The CDC recommends pausing and carefully reassessing benefits versus risks before increasing dosages to ≥50 MME/day 1
  • Many patients do not experience additional benefit in pain or function from increasing opioid dosages to ≥50 MME/day but face progressive increases in risk 1
  • Dosages beyond 50 MME/day show diminishing returns in benefits relative to risks 1

Practical Conversion Approach

If converting from the current hydrocodone regimen to long-acting oxycodone: 1, 2

  1. Calculate the theoretical equivalent: 40 mg oxycodone daily
  2. Reduce by 25-50% for safety: Start with 20-30 mg oxycodone daily
  3. Typical dosing: OxyContin 10-15 mg twice daily
  4. Provide immediate-release opioid for breakthrough pain during titration
  5. Reassess within 1-4 days and adjust based on pain control and adverse effects

Common Pitfalls to Avoid

  • Never use calculated MME directly as the conversion dose without reduction for incomplete cross-tolerance 1
  • Do not prescribe extended-release formulations to opioid-naïve patients 2
  • Monitor for acetaminophen toxicity in the current regimen (1,950 mg daily from 6 tablets) 1
  • Ensure adequate breakthrough pain coverage during any opioid rotation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid Equivalence and Dosage Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.